- Home
- SVA vs GM Comparison
SVA vs GM Comparison
Compare SVA & GM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- GM
- Stock Information
- Founded
- SVA N/A
- GM 1908
- Country
- SVA
- GM United States
- Employees
- SVA 3261
- GM N/A
- Industry
- SVA
- GM Auto Manufacturing
- Sector
- SVA
- GM Consumer Discretionary
- Exchange
- SVA NYSE
- GM Nasdaq
- Market Cap
- SVA N/A
- GM N/A
- IPO Year
- SVA N/A
- GM N/A
- Fundamental
- Price
- SVA $6.47
- GM $55.67
- Analyst Decision
- SVA
- GM Buy
- Analyst Count
- SVA 0
- GM 19
- Target Price
- SVA N/A
- GM $58.91
- AVG Volume (30 Days)
- SVA N/A
- GM 11.6M
- Earning Date
- SVA N/A
- GM 10-22-2024
- Dividend Yield
- SVA N/A
- GM 0.86%
- EPS Growth
- SVA N/A
- GM 30.21
- EPS
- SVA N/A
- GM 9.25
- Revenue
- SVA N/A
- GM $182,719,000,000.00
- Revenue This Year
- SVA N/A
- GM $8.98
- Revenue Next Year
- SVA N/A
- GM N/A
- P/E Ratio
- SVA N/A
- GM $6.02
- Revenue Growth
- SVA N/A
- GM 6.25
- 52 Week Low
- SVA N/A
- GM $27.94
- 52 Week High
- SVA N/A
- GM $59.39
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- GM 60.10
- Support Level
- SVA N/A
- GM $54.58
- Resistance Level
- SVA N/A
- GM $59.39
- Average True Range (ATR)
- SVA 0.00
- GM 1.60
- MACD
- SVA 0.00
- GM -0.25
- Stochastic Oscillator
- SVA 0.00
- GM 55.71
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.